Key result
During the first year of insulin therapy, female and male type 2 diabetic patients achieved similar weight gain (+2.5% vs +2.6%) and HbA1c reduction, despite women having higher baseline BMI.
Why the study?
Are there gender-associated differences in weight gain, insulin requirement, and metabolic control in newly insulin-treated type 2 diabetic patients with secondary sulfonylurea failure?
Observational (n=102)
Are there gender-associated differences in weight gain, insulin requirement, and metabolic control in newly insulin-treated type 2 diabetic patients with secondary sulfonylurea failure?
In newly insulin-treated type 2 diabetic patients, women start with higher BMI and insulin requirements than men, but experience similar weight gain and metabolic improvement over the first year.
May reassure on similar short-term insulin responses across genders; leaves open longer-term BMI effects in type 2 diabetes.
Objective The aim of the present study was to determine differences between male and female type 2 diabetic patients concerning body weight, metabolic control, insulin requirement and prevalence of vascular diseases during the first year insulin therapy. Patients and Methods We investigated 102 newly insulin-treated type 2 diabetic patients (60 female) with secondary sulfonylurea failure. Observation period was the first year insulin therapy. We compared BMI, HbA1c, lipids and insulin requirement at the begin and after one year, C-peptide and prevalence of vascular diseases at the start of insulin therapy. Results At the start of insulin substitution, omen had a higher BMI (27 + 3 versus 25 + 3; p < 0.05). Women also required a higher insulin dose than did men (28 + 6 versus 24 + 6 IU/day) Mean HbA1c and cholesterol levels were similar in both groups whereas triglycerides were higher in women (244 + 88 versus 203 + 76 mg/dl; p < 0.05). Both groups achieved a similar gain in body weight after one year (+2.5% versus +2.6%; NS). HbA1c decreased from 9.2 + 1.1 to 7.4% + 0.9% (–19%) in women and from 9.4 + 1.1 to 7.5% + 1.0% (–20%) in men. The prevalence of vascular diseases was not significantly different in both groups. Conclusions At the start of insulin therapy female type 2 diabetic patients showed a significant higher BMI and a higher insulin requirement than male patients. The metabolic control was similar in men and women, only the triglycerides were higher in the female patients. Weight gain and increase of needed insulin as well as prevalence of macroangiopathy were the same in both groups.
No takes yet. Share an insight, caveat, or question.
Biesenbach et al. (2009) conducted an observational in Type 2 diabetes with secondary sulfonylurea failure (n=102). Female gender vs. Male gender was evaluated on Weight gain after one year (p=NS). During the first year of insulin therapy, female and male type 2 diabetic patients achieved similar weight gain (+2.5% vs +2.6%) and HbA1c reduction, despite women having higher baseline BMI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: